Carl Hoh
Research Subjects
Carl Hoh has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Dorian S. Houser
National Marine Mammal Foundation
4 shared publications - Sam H. Ridgway
National Marine Mammal Foundation, San Diego, California, United States of America
4 shared publications - James J. Finneran
Naval Information Warfare Center Pacific
3 shared publications - Razelle Kurzrock
Genomic Sciences and Precision Medicine Center, and Medical College of Wisconsin Cancer Center, Milwaukee, WI
2 shared publications - Robert F. Mattrey
Radiology, UT Southwestern Medical Ctr., Dallas, TX
2 shared publications - Aaron M. Goodman
Department of Medicine, Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, CA 92093, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (1) , 30.e1-30.e7
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas
- 1 January 2022
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (1) , 30.e1-30.e7
Open AccessAssessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas
- Open Access
- 9 December 2020
- Published by Springer Nature in EJNMMI Research
- Vol. 10 (1) , 1-7
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients
Purpose: Deriving links between imaging and genomic markers is an evolving field. 2-[18F]FDG PET/CT (18F-fluorodeoxyglucose positron emission tomography–computed tomography) is commonly used for cancer imaging, with maximum standardized uptake value (SUVmax) as the main quantitative parameter. Tumor mutational burden (TMB), the quantitative variable obtained using next-generation sequencing on a tissue biopsy sample, is a putative immunotherapy response predictor. We report the relationship between TMB and SUVmax, linking these two important parameters. Methods: In this pilot study, we analyzed 1923 patients with diverse cancers and available TMB values. Overall, 273 patients met our eligibility criteria in that they had no systemic treatment prior to imaging/biopsy, and also had 2-[18F]FDG PET/CT within 6 months prior to the tissue biopsy, to ensure acceptable temporal correlation between imaging and genomic evaluation. Results: We found a linear correlation between TMB and SUVmax (p < 0.001). In the multivariate analysis, only TMB independently correlated with SUVmax, whereas age, gender, and tumor organ did not. Conclusion: Our observations link SUVmax in readily available, routinely used, and noninvasive 2-[18F]FDG PET/CT imaging to the TMB, which requires a tissue biopsy and time to process. Since higher TMB has been implicated as a prognostic biomarker for better outcomes after immunotherapy, further investigation will be needed to determine if SUVmax can stratify patient response to immunotherapy.
- 9 December 2020
- Published by Springer Nature in EJNMMI Research
- Vol. 10 (1) , 1-7
Open AccessRelationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients
Purpose: Deriving links between imaging and genomic markers is an evolving field. 2-[18F]FDG PET/CT (18F-fluorodeoxyglucose positron emission tomography–computed tomography) is commonly used for cancer imaging, with maximum standardized uptake value (SUVmax) as the main quantitative parameter. Tumor mutational burden (TMB), the quantitative variable obtained using next-generation sequencing on a tissue biopsy sample, is a putative immunotherapy response predictor. We report the relationship between TMB and SUVmax, linking these two important parameters. Methods: In this pilot study, we analyzed 1923 patients with diverse cancers and available TMB values. Overall, 273 patients met our eligibility criteria in that they had no systemic treatment prior to imaging/biopsy, and also had 2-[18F]FDG PET/CT within 6 months prior to the tissue biopsy, to ensure acceptable temporal correlation between imaging and genomic evaluation. Results: We found a linear correlation between TMB and SUVmax (p < 0.001). In the multivariate analysis, only TMB independently correlated with SUVmax, whereas age, gender, and tumor organ did not. Conclusion: Our observations link SUVmax in readily available, routinely used, and noninvasive 2-[18F]FDG PET/CT imaging to the TMB, which requires a tissue biopsy and time to process. Since higher TMB has been implicated as a prognostic biomarker for better outcomes after immunotherapy, further investigation will be needed to determine if SUVmax can stratify patient response to immunotherapy.
- 1 September 2010
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 128 (3) , 1460-1466
Relationship of blood flow and metabolism to acoustic processing centers of the dolphin brain
Odontocete braintissues associated with auditory processing are hypertrophied and modified relative to their terrestrial counterparts. The relationship between the functional demand on these tissues and metabolic substrate requirements is unknown. Using positron emission tomography(PET), relative cerebral blood flow was measured in a bottlenose dolphin. Approximately 60 mCi N 13 H 3 was administered to the dolphin via a catheter inserted into the hepatic vein and threaded proximate to the vena cava. Radiolabel initially appeared as distributed focal points in the cerebellum. Increasing scan time resulted in an increase in the number of focal regions and in the diffusivity of label activity throughout the brain. The time course and spatial distribution of radiolabel was consistent with a cerebral blood supply dominated by the spinal meningeal arteries.Blood flow was predominantly observed in the cerebellum and neocortex, particularly the auditory and visual cortex. Differential brain glucose uptake, previously measured in a separate dolphin, showed good agreement with the differential supply of blood to braintissues. Rates of blood supply and glucose uptake in the auditory cortex, inferior colliculus, and cerebellum are consistent with a high metabolic demand of tissues which are important to the integration of auditory and other sensory inputs.
- 1 September 2010
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 128 (3) , 1460-1466
Relationship of blood flow and metabolism to acoustic processing centers of the dolphin brain
Odontocete braintissues associated with auditory processing are hypertrophied and modified relative to their terrestrial counterparts. The relationship between the functional demand on these tissues and metabolic substrate requirements is unknown. Using positron emission tomography(PET), relative cerebral blood flow was measured in a bottlenose dolphin. Approximately 60 mCi N 13 H 3 was administered to the dolphin via a catheter inserted into the hepatic vein and threaded proximate to the vena cava. Radiolabel initially appeared as distributed focal points in the cerebellum. Increasing scan time resulted in an increase in the number of focal regions and in the diffusivity of label activity throughout the brain. The time course and spatial distribution of radiolabel was consistent with a cerebral blood supply dominated by the spinal meningeal arteries.Blood flow was predominantly observed in the cerebellum and neocortex, particularly the auditory and visual cortex. Differential brain glucose uptake, previously measured in a separate dolphin, showed good agreement with the differential supply of blood to braintissues. Rates of blood supply and glucose uptake in the auditory cortex, inferior colliculus, and cerebellum are consistent with a high metabolic demand of tissues which are important to the integration of auditory and other sensory inputs.
- 1 May 2006
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 119 (5_Suppleme) , 3276
A dolphin acoustic tapetum?
- 1 May 2006
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 119 (5_Suppleme) , 3276
A dolphin acoustic tapetum?
- 1 October 2003
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 114 (4_Suppleme) , 2434
Structural (CT) and functional imaging (PET/SPECT) for the investigation of dolphin bioacoustics
- 1 October 2003
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 114 (4_Suppleme) , 2434
Structural (CT) and functional imaging (PET/SPECT) for the investigation of dolphin bioacoustics
- 1 October 2003
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 114 (4_Suppleme) , 2433
Functional brain imaging and bioacoustics in the Bottlenose dolphins, Tursiops truncatus
- 1 October 2003
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 114 (4_Suppleme) , 2433
Functional brain imaging and bioacoustics in the Bottlenose dolphins, Tursiops truncatus
- 1 April 1993
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 158 (04) , 293-298
Ganzkörper-Positronen-Emissions-Tomographie beim Mammakarzinom
Der Stellenwert der Ganzkörper-Positronen-Emissions-Tomographie mit F-18-2-Deoxy-2-Fluoro-D-Glukose wurde bei 37 Patienten mit primärem bzw. metastasiertem Mammakarzinom in der Primärdiagnostik bzw. Verlaufskontrolle prospektiv untersucht. Von 20 Patientinnen mit Verdacht auf ein primäres Mammakarzinom wurden in Korrelation zur Histologie 15 von 16 malignen und 4 von 4 benignen Tumoren diagnostiziert. Bei 3 von 21 Patientinnen mit metastasierter Erkrankung wurde in Korrelation zur morphologisch-bild-gebenden Diagnostik/Biopsie ein falsch-negativer Befund erhoben. Diese initialen Ergebnisse lassen die Ganzkörper-Positronen-Emissions-Tomographie zur Erfassung des Krankheitsstadiums beim Mammakarzinom als ein geeignetes bildgebendes Stagingverfahren erscheinen. The value of whole body positron emission tomography using F-18 2-deoxy-2-fluoro-d-glucose in primary work-up and follow-up was prospectively evaluated in 37 patients with primary or metastatic breast cancer. From 20 primary breast masses 15 from 16 malignant and 4 from 4 benign lesions confirmed by biopsy, were detected. In 3 out of 21 patients in correlation to morphologic imaging, respectively biopsy, no metastatic disease was not identified. Generally speaking, whole body positron emission tomography appears to be a suitable diagnostic staging tool in breast cancer.
- 1 April 1993
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 158 (04) , 293-298
Ganzkörper-Positronen-Emissions-Tomographie beim Mammakarzinom
Der Stellenwert der Ganzkörper-Positronen-Emissions-Tomographie mit F-18-2-Deoxy-2-Fluoro-D-Glukose wurde bei 37 Patienten mit primärem bzw. metastasiertem Mammakarzinom in der Primärdiagnostik bzw. Verlaufskontrolle prospektiv untersucht. Von 20 Patientinnen mit Verdacht auf ein primäres Mammakarzinom wurden in Korrelation zur Histologie 15 von 16 malignen und 4 von 4 benignen Tumoren diagnostiziert. Bei 3 von 21 Patientinnen mit metastasierter Erkrankung wurde in Korrelation zur morphologisch-bild-gebenden Diagnostik/Biopsie ein falsch-negativer Befund erhoben. Diese initialen Ergebnisse lassen die Ganzkörper-Positronen-Emissions-Tomographie zur Erfassung des Krankheitsstadiums beim Mammakarzinom als ein geeignetes bildgebendes Stagingverfahren erscheinen. The value of whole body positron emission tomography using F-18 2-deoxy-2-fluoro-d-glucose in primary work-up and follow-up was prospectively evaluated in 37 patients with primary or metastatic breast cancer. From 20 primary breast masses 15 from 16 malignant and 4 from 4 benign lesions confirmed by biopsy, were detected. In 3 out of 21 patients in correlation to morphologic imaging, respectively biopsy, no metastatic disease was not identified. Generally speaking, whole body positron emission tomography appears to be a suitable diagnostic staging tool in breast cancer.